Breathe Well Live Well
|
Research and Markets: Forecast Insight: Asthma/COPD – Pipeline Potential …
Business Wire (press release) This report estimates that in 2009 asthma/COPD sales reached $21.5 billion in the seven major markets. The next 10 years will see the dynamic pipeline … |
View full post on asthma – Google News
|
Boston Scientific closes Asthmatx takeover
Trading Markets (press release) Under the terms of the agreement, the buyer paid an initial price of USD193.5m (EUR140m) for the asthma specialist, whose former shareholders may also get … Boston Scientific completes Asthmatx buyout Boston Scientific Completes Acquisition of Asthmatx |
View full post on asthma – Google News
|
Research and Markets: -Research and Markets: ABC of Asthma, 6th Edition: A …
Trading Markets (press release) For full details on (JW/A) JW/A. (JW/A) has Short Term PowerRatings at TradingMarkets. Details on (JW/A) Short Term PowerRatings is available at This Link. … |
View full post on asthma – Google News
 Daily Rosetta |
Investor group to sell Asthmatx to Boston Scientific
Trading Markets (press release) The addition of Asthmatx's products will allow Boston Scientific to expand its reach to patients suffering the effects of severe asthma. … Boston Scientific to Acquire Asthmatx Boston Scientific Corporation To Buy Asthmatx Inc. For US$443 Million Boston Scientific Locks Down Asthma Co Asthmatx For $443.5 Mln (BSX) |
View full post on asthma – Google News
|
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform
Trading Markets (press release) Flutiform is used for adult and adolescent asthma. Under the terms of the agreement, Kos has the right to perform further clinical development for … Abbott, Skyepharma Part Ways On Asthma Drug Flutiform |
View full post on asthma – Google News
Research and Markets: Obstetric Clinical Algorithms: Management and Evidence
DUBLIN—-Research and Markets has announced the addition of John Wiley and Sons Ltd’s new report “Obstetric Clinical Algorithms: Management and Evidence” to their offering.
Read more on Business Wire via Yahoo! Finance